Phast Corp.
Explore this company’s associated devices, FDA decisions and regulatory history.

Phast Corp.
- Regulatory records
- 1
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 1 FDA record to the applicant name Phast Corp.. The collection includes 1 510(k) clearance. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Jun 26, 2026 to Jun 26, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code SAN appears in 1 of the 1 linked filings. The collection spans 1 FDA product code. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 38 Wareham St., Floor 2, Boston, MA, 02118, US. Recorded on K253316, decision dated Jun 26, 2026.
Device categories in this collection
Automated Antimicrobial Susceptibility Test System For Positive Blood Culture Samples.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Regulatory record history
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Phast Corp. | 510(k) clearance | Jun 26, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.
